FDA approves GSK RSV vaccine for adults ages 50 to 59

A view shows the headquarters of GlaxoSmithKline in London, Britain, on January 17, 2022. Hannah Mckay | Reuters The Food…

FDA approves Moderna RSV vaccine for seniors

Nikos Pekiaridis | Light rocket | fake images The Food and Drug Administration on Friday approved modern Respiratory syncytial virus…